Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Physicians Who Take Vacation Time, Avoid Working on Vacation Less Likely to Suffer Burnout
January 12th 2024A survey of more than 3000 US physicians is shedding light on the impact of taking vacation time and avoiding physician-related work on vacation can have on burnout and achieving professional fulfillment.
Read More
Endocrinology Month in Review: December 2023
January 4th 2024Our endocrinology month in review spotlights our most popular content from December 2023. Our list of the most popular content from the past month includes the ADA Standards of Care—2024, label updates, a feature from our This Year in Medicine series, and more!
Read More
Cardiology Month in Review: December 2023
January 3rd 2024Our cardiology month in review spotlights our most popular cardiology-centric content from the month of December 2023. The list includes topline data from SEQUOIA-HCM, new data on the impact of structural racism on chronic health conditions, and more!
Read More
STRONG-HF Analysis: More Rapid Uptitration of Heart Failure Therapies Confers Greater Benefit
January 1st 2024Post hoc analysis of STRONG-HF trial underscores benefits of higher guideline-directed medical therapy doses in acute heart failure, showing lower rates of death or readmission at 6 months with more rapid uptitration.
Read More
Study Finds Private Equity Takeovers Increase Adverse Event, Infection Rates at Hospitals
December 26th 2023Study raises concerns about quality of care in the future, as results reveal private equity takeovers of hospitals associated with increased hospital-acquired adverse events, including falls and infections.
Read More
FDA Approves Eplontersen (Wainua) for ATTRv Polyneuropathy
December 22nd 2023The FDA has approved eplontersen (Wainua) for treating polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis, making it the only medication approved for self-administration via auto-injector pen for this condition.
Read More
SUMMIT: Bezuclastinib Demonstrates Reduction in NonAdvSM Symptoms
December 9th 2023Bezuclastinib, a targeted oral therapy, shows promise in reducing disease burden and improving symptoms by 50% or more in nonadvanced systemic mastocytosis patients, as revealed in the phase 2 SUMMIT trial data presented at ASH 2023.
Read More
Sex- and Race-Based Disparities Perpetuate Suboptimal Testing for Colorectal Cancer
November 29th 2023An analysis of data from the Veterans Health Administration provides insight into disparities in the rates of endoscopy or colonoscopy among patients with iron deficiency anemia or hematochezia.
Read More